Akers Biosciences Announces a Change to the Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Akers Biosciences (AKER) Announces Raymond Akers has Resigned as Director
May 29, 2018 7:08 AM EDTAkers Biosciences, Inc. (NASDAQ: AKER), announces that Raymond F. Akers Jr., Ph.D has resigned as a director of the Company with immediate effect.
Pursuant to U.S. Federal Securities Laws, within four business days the Company will file a Form 8-K with... More
